Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives

Artem Blagodatski1,2, Antonina Klimenko1, Lee Jia3,4

  • 1School of Biomedicine, Far Eastern Federal University, Vladivostok 690090, Russia.

Cells
|March 6, 2020
PubMed

Insights

Natural products offer small molecules that modulate Wnt signaling, a key pathway in development and disease. These compounds show potential as activators for regenerative medicine and inhibitors for cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Wnt signaling is crucial for embryonic development, tissue renewal, and regeneration.
  • Pathway dysregulation is linked to cancer, osteoporosis, and rheumatoid arthritis, making it a therapeutic target.
  • Small molecules, particularly natural products, are valuable tools for modulating Wnt signaling.

Purpose of the Study:

  • To provide an overview of natural product-derived small molecule modulators of the Wnt pathway.
  • To discuss Wnt pathway activators for regenerative therapies.
  • To describe Wnt pathway inhibitors for cancer treatment.

Main Methods:

  • Literature review of natural products affecting Wnt signaling.
  • Analysis of mechanisms of action for identified compounds.
  • Evaluation of therapeutic potential and source taxa.

Main Results:

  • Identified natural products acting as Wnt pathway activators for regenerative applications (skin, bone, cartilage, nervous system).
  • Identified natural products acting as Wnt pathway inhibitors for cancer therapy.
  • Highlighted the potential of diverse taxa as sources of Wnt-modulating compounds.

Conclusions:

  • Natural products represent a rich source of Wnt signaling modulators.
  • Wnt pathway activators from natural products hold promise for regenerative medicine.
  • Wnt pathway inhibitors from natural products are potential candidates for targeted cancer therapies.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.1K